Vestmark Advisory Solutions, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vestmark Advisory Solutions, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$941,165
-0.6%
72,733
+6.7%
0.04%
-4.9%
Q1 2024$947,181
+2.2%
68,192
+5.0%
0.04%
-12.8%
Q4 2023$926,403
-5.9%
64,920
+2.0%
0.05%
-34.7%
Q3 2023$984,350
-0.2%
63,630
+1.4%
0.07%
+89.5%
Q2 2023$985,953
-5.6%
62,760
-0.9%
0.04%
-15.6%
Q1 2023$1,044,084
+10.3%
63,354
+4.4%
0.04%
-2.2%
Q4 2022$946,243
+17.3%
60,656
-2.5%
0.05%
+2.2%
Q3 2022$807,00062,2200.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders